487 related articles for article (PubMed ID: 26031592)
1. Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies.
Niikura T; Yamamoto I; Nakada Y; Kamejima S; Katsumata H; Yamakawa T; Furuya M; Mafune A; Kobayashi A; Tanno Y; Miki J; Yamada H; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():75-8. PubMed ID: 26031592
[TBL] [Abstract][Full Text] [Related]
2. A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient.
Fujimoto T; Nakada Y; Yamamoto I; Kobayashi A; Tanno Y; Yamada H; Miki J; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():81-5. PubMed ID: 26031594
[TBL] [Abstract][Full Text] [Related]
3. Acute T cell-mediated rejection accompanied by C4d-negative acute antibody-mediated rejection and cell debris in tubulus: A case report.
Takamura T; Yamamoto I; Nakada Y; Katsumata H; Yamakawa T; Furuya M; Mafune A; Kobayashi A; Tanno Y; Miki J; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():70-4. PubMed ID: 26031591
[TBL] [Abstract][Full Text] [Related]
4. Subclinical antibody-mediated rejection due to anti-human-leukocyte-antigen-DR53 antibody accompanied by plasma cell-rich acute rejection in a patient with cadaveric kidney transplantation.
Katsuma A; Yamamoto I; Komatsuzaki Y; Niikura T; Kawabe M; Okabayashi Y; Yamakawa T; Katsumata H; Nakada Y; Kobayashi A; Tanno Y; Miki J; Yamada H; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():31-4. PubMed ID: 26971538
[TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated rejection due to anti-HLA-DQ antibody after pregnancy and delivery in a female kidney transplant recipient.
Sagasaki M; Nakada Y; Yamamoto I; Kawabe M; Yamakawa T; Katsumata H; Mafune A; Katsuma A; Kobayashi A; Koike K; Koike Y; Miki J; Yamada H; Kimura T; Tanno Y; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
Nephrology (Carlton); 2018 Jul; 23 Suppl 2():81-84. PubMed ID: 29968405
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic analysis of acute vascular rejection cases after renal transplantation.
Shimizu T; Tanabe T; Omoto K; Ishida H; Tanabe K
Transplant Proc; 2012 Jan; 44(1):230-5. PubMed ID: 22310621
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
8. Plasma cell-rich rejection accompanied by acute antibody-mediated rejection in a patient with ABO-incompatible kidney transplantation.
Furuya M; Yamamoto I; Kobayashi A; Nakada Y; Sugano N; Tanno Y; Ohkido I; Tsuboi N; Yamamoto H; Yokoyama K; Yokoo T
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():31-4. PubMed ID: 24842819
[TBL] [Abstract][Full Text] [Related]
9. A case of acute antidonor antibody-mediated humoral rejection after renal transplantation with specific consideration of serial graft biopsy histology.
Shimizu T; Tokiwa M; Yamaguchi Y
Clin Transplant; 2002; 16 Suppl 8():62-7. PubMed ID: 12464135
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pathological analyses of transplant glomerulopathy cases.
Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
[TBL] [Abstract][Full Text] [Related]
11. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
[TBL] [Abstract][Full Text] [Related]
12. The clinical and molecular significance of C4d staining patterns in renal allografts.
Hayde N; Bao Y; Pullman J; Ye B; Calder BR; Chung M; Schwartz D; Alansari A; de Boccardo G; Ling M; Akalin E
Transplantation; 2013 Feb; 95(4):580-8. PubMed ID: 23274969
[TBL] [Abstract][Full Text] [Related]
13. Biopsy findings on a stable recipient after secondary donor specific antibody (DSA) positive and ABO incompatible kidney transplantation.
Sugitani A; Takahashi C; Naka T; Hisamitsu K; Yamamoto O; Kobayashi N; Kimura M; Yoshida H; Hanaki T; Hamazoe R
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():79-80. PubMed ID: 26031593
[TBL] [Abstract][Full Text] [Related]
14. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
[TBL] [Abstract][Full Text] [Related]
15. Treatment of acute antibody-mediated rejection using bortezomib: a case report.
Sin YH; Kim YJ; Oh JS; Lee JH; Kim SM; Kim JK
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():86-9. PubMed ID: 26031595
[TBL] [Abstract][Full Text] [Related]
16. Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts.
Collins AB; Chicano SL; Cornell LD; Tolkoff-Rubin N; Goes NB; Saidman SL; Farrell ML; Cosimi AB; Colvin RB
Transplant Proc; 2006 Dec; 38(10):3427-9. PubMed ID: 17175293
[TBL] [Abstract][Full Text] [Related]
17. A suspected case of plasma cell-rich acute renal transplant rejection associated with de novo donor-specific antibody.
Yoshikawa M; Kitamura K; Ishimura T; Hara S; Fujisawa M; Nishi S
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():66-9. PubMed ID: 26031590
[TBL] [Abstract][Full Text] [Related]
18. Acute transplant glomerulopathy is associated with antibody-mediated rejection and poor graft outcome.
Nair R; Fraer M; Agrawal N; Suneja M
Transplant Proc; 2010 Nov; 42(9):3507-12. PubMed ID: 21094805
[TBL] [Abstract][Full Text] [Related]
19. The impact of C4d staining as a humoral injury marker.
Kara M; Demir F; Ata P; Ozel L; Gumrukcu G; Unal E; Canbakan M; Gucun M; Esadoglu V; Ozdemir E; Cemel H; Titiz MI
Transplant Proc; 2012; 44(6):1694-6. PubMed ID: 22841245
[TBL] [Abstract][Full Text] [Related]
20. Antibody-mediated rejection and treatment in pediatric patients: one center's experience.
Gulleroglu K; Baskin E; Bayrakci US; Turan M; Ozdemir BH; Moray G; Karakayali H; Haberal M
Exp Clin Transplant; 2013 Oct; 11(5):404-7. PubMed ID: 24128133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
